Effects of Dialogue Meetings - Pre-analysis plan Phase 1

Last registered on February 13, 2018

Pre-Trial

Trial Information

General Information

Title
Effects of Dialogue Meetings - Pre-analysis plan Phase 1
RCT ID
AEARCTR-0002730
Initial registration date
February 12, 2018

Initial registration date is when the trial was registered.

It corresponds to when the registration was submitted to the Registry to be reviewed for publication.

First published
February 13, 2018, 1:59 PM EST

First published corresponds to when the trial was first made public on the Registry after being reviewed.

Locations

Region

Primary Investigator

Affiliation
University of Oslo

Other Primary Investigator(s)

PI Affiliation
PI Affiliation
PI Affiliation

Additional Trial Information

Status
On going
Start date
2016-09-12
End date
2019-12-30
Secondary IDs
Abstract
Sickness absence entails large individual and societal costs. Dialogue Meetings (DMs) where the absentee, the employer, and often the physician, discuss arrangements for full or partial work resumption have been in place in Norway since 2007. In collaboration with the Norwegian Labour and Welfare Administration (NAV) we are conducting a large scale randomized natural field experiment to investigate if and for whom DMs have effects. The experiment is still ongoing and is conducted in several phases to test for mechanisms iteratively. While the experiment is still ongoing, it is possible to analyze data on the individuals that have already been involved in the experiment so far (early sample). To do so we proceeded as follows: first, we randomly divided the early sample into an early training sample and an early test sample. NAV then merged the early training sample with outcome data and covariates and handed the data over to us. Based on the results in the early training sample, we here register some key decisions that will be followed in analyzing the rest of the data (the analysis sample, which comprises the late sample and the early test sample). The results from the early training sample are presented in a companion document and will be subject to a direct replication using the early test sample. Based on the findings in the early test sample we will decide whether and how to change the intervention. Such changes will be pre-registered at a later stage.
External Link(s)

Registration Citation

Citation
Alpino, Matteo et al. 2018. "Effects of Dialogue Meetings - Pre-analysis plan Phase 1." AEA RCT Registry. February 13. https://doi.org/10.1257/rct.2730-1.0
Former Citation
Alpino, Matteo et al. 2018. "Effects of Dialogue Meetings - Pre-analysis plan Phase 1." AEA RCT Registry. February 13. https://www.socialscienceregistry.org/trials/2730/history/25764
Experimental Details

Interventions

Intervention(s)
In order test the causal effect of the Dialogue Meetings we team up with the Norwegian Labour and Welfare Administration (NAV) to conduct a large scale randomized field experiment. In particular, we randomize: 1) whether people receive letters calling them in to mandatory or voluntary meetings; 2) when in the sickness spell they receive the letter; 3) and when the meeting is scheduled (if mandatory).
Intervention Start Date
2016-09-12
Intervention End Date
2019-12-30

Primary Outcomes

Primary Outcomes (end points)
Total number of days of sickness absence
Primary Outcomes (explanation)
See the attached plan.

Secondary Outcomes

Secondary Outcomes (end points)
See the attached plan.
Secondary Outcomes (explanation)

Experimental Design

Experimental Design
In order test the causal effect of the Dialogue Meetings we team up with the Norwegian Labour and Welfare Administration (NAV) to conduct a large scale randomized field experiment. In particular, we randomize: 1) whether people receive letters calling them in to mandatory or voluntary meetings; 2) when in the sickness spell they receive the letter; 3) and when the meeting is scheduled (if mandatory).
Experimental Design Details
Randomization Method
Randomization is done by a computer on a secured internet page.
Randomization Unit
Individual
Was the treatment clustered?
No

Experiment Characteristics

Sample size: planned number of clusters
At least 7900 individuals
Sample size: planned number of observations
At least 7900 individuals
Sample size (or number of clusters) by treatment arms
Around 50/50 for main analysis. 12.5 percent in 6 treatment arms, 25 in one for mechanisms.
Minimum detectable effect size for main outcomes (accounting for sample design and clustering)
0.063 Standard Deviations (less than 6 total days of absence)
Supporting Documents and Materials

There is information in this trial unavailable to the public. Use the button below to request access.

Request Information
IRB

Institutional Review Boards (IRBs)

IRB Name
IRB Approval Date
IRB Approval Number
Analysis Plan

There is information in this trial unavailable to the public. Use the button below to request access.

Request Information

Post-Trial

Post Trial Information

Study Withdrawal

There is information in this trial unavailable to the public. Use the button below to request access.

Request Information

Intervention

Is the intervention completed?
No
Data Collection Complete
Data Publication

Data Publication

Is public data available?
No

Program Files

Program Files
Reports, Papers & Other Materials

Relevant Paper(s)

Reports & Other Materials